CSL

CSL Behring Kankakee Illinois site

Pharma

CSL cuts FY26 revenue projection by $600M, writes off $5B

CSL has slashed its revenue projection for the fiscal year from $15.8 billion to $15.2 billion and is taking a $5 billion asset impairment.

Kevin Dunleavy May 11, 2026 11:30am

drug prices biologics drug costs IRA money cash payment co-pay

Top 20 pharma companies by 2025 revenue

Apr 20, 2026 3:00am

CSL CSL Behring Kankakee Illinois

CSL firms up details on $1.5B US plasma-based medicines plant

Mar 10, 2026 10:30am

image of CSLs new RD facility

CSL details sales slide behind recent leadership transition

Feb 12, 2026 8:29am

Open door symbolizing exit

Beleaguered CSL announces surprise CEO retirement

Feb 10, 2026 10:45am

FDA

FDA proposes flu shot labels include warnings for febrile seizures

Jan 15, 2026 12:07pm